Edward Weinstein

Edward Weinstein is a seasoned executive and entrepreneur in the life sciences industry with extensive experience in leadership roles across various biotech and pharmaceutical companies. Here are some key details about his career and background:

Professional Experience

Edward Weinstein currently serves as the Co-Founder and CEO of Panome Bio, a company he started in November 2022 that offers proteomics and Next-Generation Metabolomics assays for drug discovery, pathway analysis, and biomarker development.12

Prior to his current role, Weinstein was the President and CEO of Canopy Biosciences from October 2016 to April 2022. Canopy Biosciences is a Contract Research Organization (CRO) that focuses on accelerating the commercialization of life science reagent tools and services.13

Some of his other notable positions include:

• Adjunct Professor at The Robert Larner, M.D. College of Medicine at The University of Vermont (2014-2018)
• Entrepreneur in Residence at BioGenerator (2016-2017)
• President at Horizon Discovery (2014-2016)
• President at SAGE Labs (2013-2014)
• Director and Manager of Operations at Sigma Aldrich (2005-2013)
• Senior Scientist at Merck (2003-2005)
• Senior Biologist at Pfizer (2000-2003)1

Education

Weinstein holds a Ph.D. in Genetics from Harvard University (1994-2000), where he focused on creating animal models of breast and ovarian cancer. He also earned a BS in Cellular Molecular Biology/Chemistry from the University of Michigan (1989-1993).1

Achievements and Expertise

As the CEO of Canopy Biosciences, Weinstein led the company to significant growth and success. Under his leadership, Canopy Biosciences developed a comprehensive portfolio of products and services for gene editing, gene expression analysis, and bioprocessing.4 The company was acquired by Bruker Corporation in September 2020, a testament to its success in the field.4

Weinstein is known for his innovative approach to business development in the biotech industry. At Canopy Biosciences, he implemented a strategy of acquiring technologies that were already developed and ready for commercialization, rather than focusing on a single technology.3

Personal Attributes

Colleagues describe Weinstein as a dynamic and visionary leader. He is committed to customer service and has worked to make Canopy Biosciences stand out by offering transparent pricing and comprehensive services.3 His leadership style emphasizes innovation, customer focus, and adaptability in the fast-paced biotech industry.

Edward Weinstein's extensive experience in both academic and industrial settings, combined with his entrepreneurial spirit, has established him as a respected figure in the life sciences sector.